These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7174514)

  • 21. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
    Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PS-5, a new beta-lactam antibiotic. II. Antimicrobial activity.
    Sakamoto M; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):272-9. PubMed ID: 38238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial activity and chemical modifications of PS-5 at the C-3 side chain.
    Sakamoto M; Yamamoto K; Isshiki K; Ishikura T; Fukagawa Y; Yoshioka T
    J Antibiot (Tokyo); 1990 Oct; 43(10):1254-70. PubMed ID: 2258325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
    Mitsuhashi S
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Shinagawa M; Yasujima M; Suwabe A; Kuroda M; Kaku M; Kitagawa M; Kanemitsu K; Imafuku Y; Murakami M; Yomodu S; Taniguchi N; Yamada T; Nomura F; Kanno H; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Horikawa Y; Maekawa M; Nagura O; Yagi T; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kawano S; Kinoshita S; Taminato T; Negayama K; Murase M; Miyamoto H; Kusano N; Nose M; Yokozaki M; Itaha H; Matsunaga A; Yoshimura H; Kohno S; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2011 Apr; 64(2):53-95. PubMed ID: 21721247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-19393 S2 and H2, new carbapenem antibiotics. I. Taxonomy of the producing strain, fermentation and antibacterial properties.
    Imada A; Nozaki Y; Kintaka K; Okonogi K; Kitano K; Harada S
    J Antibiot (Tokyo); 1980 Dec; 33(12):1417-24. PubMed ID: 6788739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carbapenems: new broad spectrum beta-lactam antibiotics.
    Moellering RC; Eliopoulos GM; Sentochnik DE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():1-7. PubMed ID: 2681123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
    Yokota Y; Murakawa T; Nishida M
    J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial activity of S-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections.
    Nomura S; Nagayama A
    J Chemother; 2002 Apr; 14(2):155-60. PubMed ID: 12017370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the OA-6129 group of antibiotics, new carbapenem compounds. I. Taxonomy, isolation and physical properties.
    Okabe M; Azuma S; Kojima I; Kouno K; Okamoto R; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1982 Oct; 35(10):1255-63. PubMed ID: 7174513
    [No Abstract]   [Full Text] [Related]  

  • 36. Bactericidal activity of meropenem and interactions with other antibiotics.
    Ferrara A; Grassi G; Grassi FA; Piccioni PD; Gialdroni Grassi G
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():239-50. PubMed ID: 2808210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structures of OA-6129A, B1, B2 and C, new carbapenem antibiotics produced by Streptomyces sp. OA-6129.
    Yoshioka T; Kojima I; Isshiki K; Watanabe A; Shimauchi Y; Okabe M; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1983 Nov; 36(11):1473-82. PubMed ID: 6654757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.
    Aldridge KE; Sanders CV; Lewis AC; Marier RL
    J Med Microbiol; 1983 Feb; 16(1):75-82. PubMed ID: 6218305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-19393 S2 and H2, new carbapenem antibiotics. II. isolation and structures.
    Harada S; Shinagawa S; Nozaki Y; Asai M; Kishi T
    J Antibiot (Tokyo); 1980 Dec; 33(12):1425-30. PubMed ID: 6788740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephalosporin, thienamycin, and monobactam antibiotics: a review of antimicrobial activity, pharmacology, and safety.
    Smith BR; LeFrock JL
    J Foot Surg; 1987; 26(1 Suppl):S42-50. PubMed ID: 3549852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.